Cargando…

Sigma-2 Receptors—From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases

There is a large unmet medical need to develop disease-modifying treatment options for individuals with age-related degenerative diseases of the central nervous system. The sigma-2 receptor (S2R), encoded by TMEM97, is expressed in brain and retinal cells, and regulates cell functions via its co-rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lizama, Britney N., Kahle, Jennifer, Catalano, Susan M., Caggiano, Anthony O., Grundman, Michael, Hamby, Mary E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093856/ https://www.ncbi.nlm.nih.gov/pubmed/37047224 http://dx.doi.org/10.3390/ijms24076251

Ejemplares similares

A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
por: Grundman, Michael, et al.
Publicado: (2019)

The Six Sigma basic training kit /
Publicado: (2002)

The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles 2.0
por: Abate, Carmen, et al.
Publicado: (2023)

Pharmacology and Therapeutic Potential of Sigma(1) Receptor Ligands
por: Cobos, E.J, et al.
Publicado: (2008)

Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development
por: Ren, Peng, et al.
Publicado: (2022)

Sigma receptors [σRs]: biology in normal and diseased states
por: Rousseaux, Colin G., et al.
Publicado: (2016)

The Sigma Enigma: A Narrative Review of Sigma Receptors
por: Pergolizzi, Joseph, et al.
Publicado: (2023)

Editorial: Sigma Receptors
por: Aydar, Ebru, et al.
Publicado: (2020)

Sigma-1 receptor and neuroprotection: current outlook and potential therapeutic effects
por: Li Volti, Giovanni, et al.
Publicado: (2016)

The biology of degenerative joint disease
por: Sokoloff, Leon
Publicado: (1969)

The Biology of Degenerative Joint Disease
por: Crelin, E. S.
Publicado: (1969)

The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2020)

Sigma receptors and neurological disorders
por: Piechal, Agnieszka, et al.
Publicado: (2021)

Sigma-1 receptor and seizures
por: Vavers, Edijs, et al.
Publicado: (2023)

Sigma-1 Receptor: A Potential Therapeutic Target for Traumatic Brain Injury
por: Shi, Mingming, et al.
Publicado: (2021)

Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics
por: Berkowitz, Reed L., et al.
Publicado: (2023)

Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein
por: Limegrover, Colleen S., et al.
Publicado: (2021)

Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
por: Sałaciak, Kinga, et al.
Publicado: (2022)

A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter
por: LaBarbera, Kelsie M., et al.
Publicado: (2023)

Novel Therapeutic Approaches for the Treatment of Retinal Degenerative Diseases: Focus on CRISPR/Cas-Based Gene Editing
por: Gallego, Carmen, et al.
Publicado: (2020)

Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration
por: Verma, Manish, et al.
Publicado: (2022)

Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases
por: Munguia-Galaviz, Francisco Javier, et al.
Publicado: (2023)

Role of Sigma Receptors in Alcohol Addiction
por: Quadir, Sema G., et al.
Publicado: (2019)

Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities
por: Selvaggi, Federico, et al.
Publicado: (2023)

The intersection of change management and lean six sigma: the basics for black belts and change agents
por: Kesterson, Randy K
Publicado: (2017)

Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders
por: Terada, Kazuki, et al.
Publicado: (2019)

Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome
por: Song, LouJin, et al.
Publicado: (2022)

Injectable Biologics for the Treatment of Degenerative Disc Disease
por: Matta, Ajay, et al.
Publicado: (2020)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
por: Izzo, Nicholas J., et al.
Publicado: (2014)

Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity
por: Kaushal, Nidhi, et al.
Publicado: (2011)

The Sigma-1 Receptor in Cellular Stress Signaling
por: Hayashi, Teruo
Publicado: (2019)

The Emerging Role of Sigma Receptors in Pain Medicine
por: Pergolizzi Jr, Joseph, et al.
Publicado: (2023)

On the width of SIGMA hypernuclei and SIGMA- atoms
por: Brockmann, R, et al.
Publicado: (1982)

Sum rules for $\SIGMA\SIGMA$ (In Russian)
por: Fil'kov, L V, et al.
Publicado: (1970)

The Biological Function of Sigma-2 Receptor/TMEM97 and Its Utility in PET Imaging Studies in Cancer
por: Zeng, Chenbo, et al.
Publicado: (2020)

Structure-Based Modeling of Sigma 1 Receptor Interactions with Ligands and Cholesterol and Implications for Its Biological Function
por: Kim, Meewhi, et al.
Publicado: (2023)

Differential Responses to Sigma-1 or Sigma-2 Receptor Ablation in Adiposity, Fat Oxidation, and Sexual Dimorphism
por: Li, Jing, et al.
Publicado: (2022)

Focus and leverage: the critical methodology for theory of constraints, lean, and six sigma (TLS)
por: Nelson, Bruce, et al.
Publicado: (2015)

Novel therapeutic strategies for degenerative disc disease: Review of cell biology and intervertebral disc cell therapy
por: Fernandez-Moure, Joseph, et al.
Publicado: (2018)

The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
por: Sambo, Danielle O., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q4khmvt6sfjppq2apjcfp8vqbi